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Among multidrug-resistant bacteria, methicillin-resistant Staphylococcus aureus is emerging as one 
of the most threatening pathogens. S. aureus exploits different mechanisms for its iron supply, but 
the preferred one is acquisition of organic iron through the expression of hemoglobin (Hb) receptors. 
One of these, IsdB, belonging to the Isd (Iron-Regulated Surface Determinant) system, was shown 
to be essential for bacterial growth and virulence. Therefore, interaction of IsdB with Hb represents 
a promising target for the rational design of a new class of antibacterial molecules. However, despite 
recent investigations, many structural and mechanistic details of complex formation and heme 
extraction process are still elusive. By combining site-directed mutagenesis, absorption spectroscopy, 
surface plasmon resonance and molecular dynamics simulations, we tackled most of the so far 
unanswered questions: (i) the exact complex stoichiometry, (ii) the microscopic kinetic rates of complex 
formation, (iii) the IsdB selectivity for binding to, and extracting heme from, α and β subunits of Hb, iv) 
the role of specific amino acid residues and structural regions in driving complex formation and heme 
transfer, and (v) the structural/dynamic effect played by the hemophore on Hb.
The ability of bacterial pathogens to establish infections relies on the adaptation of bacterial metabolism to the 
environment found within the host, which is often severely nutrient-restricted and a site for competition with 
commensal microorganisms and other pathogens1,2. A well-characterized mechanism of adaptation to the nutri-
tional environment of the host is represented by the expression of redundant iron-acquisition systems, both in 
Gram+ and Gram- bacteria, to provide iron supply to support invasion and proliferation3. Iron is an essential 
nutrient for both the pathogen and the host, but also a toxic element due to its involvement in Fenton chemistry 
and Haber-Weiss reactions that generate reactive oxygen species (ROS)4. For this reason, vertebrates have put in 
place strategies to maintain very low concentrations of free iron in body fluids (down to 10−18–10−24 M)4,5 achiev-
ing two goals, the first being limiting toxicity and the second creating an iron-restricted environment for patho-
gens6,7. In S. aureus, iron scavenging is achieved by at least three different mechanisms: i) acquisition of inorganic 
iron through production of siderophores, ii) expression of hemoglobin (Hb) receptors, and iii) acquisition of 
inorganic iron through transporters4. Heme is the preferred iron source during the initial phase of infection8 
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and, indeed, S. aureus expresses two Hb receptor isoforms, called IsdB5 and IsdH9–11. They both belong to the 
so-called Isd (Iron-regulated Surface Determinant) system that comprises nine proteins (IsdA-I) responsible for 
heme extraction from Hb, heme transport through the cell wall and the membrane, and heme disassembly to get 
free ferrous ions. IsdB is responsible for heme acquisition from Hb only, whereas IsdH can capture heme from 
both free Hb and Hb-haptoglobin complex12,13. IsdB is strongly up-regulated under conditions of iron restric-
tion14. Different experimental evidences pointed out that IsdB is crucial for S. aureus proliferation and virulence. 
ΔisdB strains or strains expressing Hb-binding deficient mutants show severe growth defects in media with Hb 
as the sole iron source and have a reduced colonization capacity15. More recently the role of IsdB in adhesion to 
host cells has been pointed out, further complicating the description of its function in host-pathogen interaction 
and in virulence16,17. Its role as a virulence factor has been also recently assessed by analyzing 30 West Australian 
methicillin-resistant S. aureus (MRSA) isolates of human origin, where the IsdB gene was identified in the vast 
majority of cases18.
IsdB (Fig. 1) is characterized by a modular structure formed by the assembly of two NEAT domains (referred 
to as N1 and N2). NEAT domains are heme/Hb binding modules conserved in Gram+ bacteria. They were firstly 
identified by a bioinformatic search of putative iron transporters genic loci (the acronym stands for NEAr-iron 
Transporter19). NEAT domains display a β-sandwich fold with a central 310-helix that forms a hydrophobic cavity 
where the heme is eventually bound20. The NEAT domains are linked by rigid α-helical bundles which con-
tribute to high affinity binding of IsdB to Hb, as suggested by pull-down assays20. NEAT domains can perform 
three actions: direct heme binding, Hb binding and heme extraction, and heme transfer between NEAT domains 
of separate Isd receptors. The “heme-binding signature”21 of S. aureus and Bacillus anthracis NEAT domains is 
the five-residues sequence YXXXY, where the first Tyr residue directly binds the heme iron and the second is 
hydrogen-bonded to the first one22. Interestingly, IsdB uses only one out of two NEAT domains to bind the heme. 
Indeed, the two NEAT domains of IsdB have very low sequence identity (about 11%) and the C-terminal one (N2) 
carries the heme-binding signature sequence YDGQY, which is absent in the N-terminal sequence (N1). The N1 
domain exhibits the FYHYA sequence that is highly conserved in different S. aureus strains and is essential for Hb 
binding, as recently confirmed by Ala-scanning experiments15. Therefore, the N1 domain of IsdB is involved in 
Hb binding while N2 is involved in heme extraction23.
As also recently pointed out for IsdH24, although several studies have undertaken the structural and func-
tional characterization of the IsdB/Hb complex13,20,25, the complicated nature of the protein-protein interaction 
has often prevented to obtain concluding results about the complex dynamics24. Six 3D structures of IsdB, and 
about the double for IsdH, have been deposited in the Protein Data Bank up to now. None of them reports the 
full-length structure of the hemophores and only fragments comprising one or more domains are present. On the 
other hand, seven structures of IsdH/IsdB in complex with Hb have been deposited, with only three including 
more than one NEAT domain. The first two structures of methemoglobin (MetHb) in complex with IsdH N2 and 
N3 were solved by Dickson and co-workers in 2014 and 201526,27. Differently from IsdB, in fact, IsdH presents 
three NEAT domains, of which N1 and N2 are involved in binding Hb and N3 in extracting the heme.
The unique structure of the IsdB/Hb complex, solved by Bowden et al. in 2017, presents low resolution, heme 
dislocation and Hb helix F unfolding13. Any improvement in the knowledge of this fascinating, although compli-
cated, system is crucial to better understand the dynamics of similar systems in different pathogens and, eventu-
ally, to envisage innovative antimicrobial approaches. In this regard, the main still open questions involve (i) the 
exact complex stoichiometry in solution27; (ii) the microscopic kinetic rates that drive complex formation; (iii) the 
existence of a different efficiency for heme extraction from α and β subunits of Hb, still strongly controversial13,28; 
Figure 1. IsdB secondary and tertiary structures. (A) Topology of IsdB (PDB code 5vmm). The structure 
consists of 18 β-strands and 6 α-helices, forming two NEAT domains connected by a flexible linker. (B) 3D 
cartoon structure of wt IsdB in complex with methemoglobin (MetHb). Hb binding motif and heme binding 
signature are represented in stick residues. A and B refer, respectively, to the hemoglobin binding motif and to 
the heme-binding signature.
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(iv) the role of specific amino acid residues in driving complex formation and heme transfer, and (v) the struc-
tural/dynamic effect played by the hemophores on Hb.
We have addressed all these points by a combined in vitro and in silico approach. We investigated by UV-Vis 
spectroscopy and by surface plasmon resonance (SPR) the interaction of wild-type IsdB and the Y440A variant 
(IsdBY440A, expected to be unable to complete heme transfer13,22), with human Hb and with semiHbs. SemiHbs are 
stable Hb α/β dimers where either the α (α-semiHb) or the β (β-semiHb) subunits bind heme29 and are here used 
to detect any subunit preference in IsdB binding and heme extraction. In silico simulations were run to investigate 
the IsdB/Hb interface and identify the key residues involved in the complex recognition and in the heme extrac-
tion. Essential dynamics analyses helped us to investigate the dynamics of the complex and the structural changes 
induced on Hb by hemophore binding.
Results
Protein characterization. IsdB from S. aureus used in this study was designed to contain the two NEAT 
domains (N1 and N2) connected by the helical linker, and a C-terminal Strep-Tag® for protein purification and 
immobilization on SPR sensor chips. The wild-type protein and its variant IsdBY440A were purified in high yields, 
about 100 mg/L bacterial culture, and good homogeneity (Fig. S1A,B, respectively). The extinction coefficient at 
280 nm is 47,800 M−1 cm−1 and 46,300 M−1 cm−1 for IsdB and IsdBY440A, respectively. The extinction coefficient 
at 405 nm is 90,500 M−1 cm−1 and was calculated by using the pyridine hemochromagen assay30. The amount 
of holoIsdB was calculated to be less than 5% in the final preparation (Fig. S1C) and thus its contribution to 
Hb binding in the following experiments can be considered negligible. When IsdB is added to a solution of 
reduced, oxygenated Hb (OxyHb), the spectrum does not change and the absorbance at 406 nm is stable over time 
(Fig. 2A, inset). However, when IsdB is added to a MetHb solution (likely the dominant form interacting with 
the hemophore under in vivo infection conditions), a fast change in the absorbance spectrum is observed, with a 
decrease in the absorption maximum and a small blue-shift (Fig. 2A). This result is in agreement with literature 
data15,20,25,31 and is the spectroscopic signature of the heme transfer from Hb to IsdB. The transfer is completed 
in about 1 minute at 20 °C under pseudo-first order conditions, i.e. 7.5 µM IsdB and 1.5 µM Hb (Fig. 2A, inset). 
Fitting of the kinetic trace with a biexponential equation gives an observed kinetic rate kobs for the fast phase 
(attributed to heme transfer) of 0.2 s−1 (Table 1), in very good agreement with published data collected under 
similar conditions13,24. The spectroscopic changes associated to the heme transfer were used to perform a stoichi-
ometric titration of Hb binding to IsdB, since the stoichiometries of the IsdB/Hb complex reported in literature 
are not fully consistent20. When increasing IsdB concentrations are added to a MetHb solution the signal at 
406 nm progressively decreases until the stoichiometric ratio is reached. Further addition of IsdB does not change 
the absorbance signal (Fig. 2B). The calculated stoichiometric ratio is 1, meaning that each Hb monomer binds 
one IsdB molecule. The IsdBY440A mutant elicits a red shift in the absorption spectrum of heme, suggesting that its 
final microenvironment is different from that experienced with wt IsdB. The final spectrum is centered at 410 nm 
(Fig. 2C). When IsdB is added to a solution containing either α-semiHb or β-semiHb, spectroscopic changes sim-
ilar to those registered with native Hb are observed (Fig. 2D). Of notice, the rates of heme transfer, under identical 
conditions as those used for native Hb (Fig. 2D, inset), are very similar (kobs of 0.28 s−1 and 0.27 s−1, respectively, 
for the fast kinetic phase), suggesting that IsdB can extract the heme with comparable efficiency from α and β 
subunits (vide infra).
Determination of microscopic kinetic constants of complex formation. Literature data report 
about the affinity of the IsdB:Hb complex12,20, structure of IsdH and IsdB hemophores in complex with Hb, also 
with isolated domains27,32, and mechanism/kinetics of heme transfer15,24,25,31,33–35. However, key information is 
missing on the dynamics of complex formation and on the subtle mechanisms that control the kinetics of the 
heme transfer. SPR experiments were carried out on different IsdB (wt and Y440A mutant) and Hb variants 
(OxyHb, MetHb and semiHbs) under the same experimental conditions, to define the simplest kinetic model and 
determine the microscopic rate constants for the individual steps.
Also based on literature data on similar systems24, a general kinetic model for complex formation with Hb and 
heme extraction can be represented as follows:
+ → + IsdB MetHb IsdB :MetHb IsdB :Hb IsdB Hbapo apo holo apo holo apo
IsdB forms an encounter complex with MetHb, followed by heme extraction and by complex dissociation. 
The heme removal step is assumed to be irreversible based on published data on IsdH24 and on the expected 
extensive conformational changes towards a partially unfolded state occurring on Hb upon heme transfer13. On 
the other hand, OxyHb binds IsdB without transferring heme (Fig. 2A, inset) and, thus, only the first, reversible 
step is sufficient to describe the interaction. Therefore, SPR experiments were firstly carried out on OxyHb which 
represents a simplified model for the IsdB:Hb interaction. The sensorgrams obtained from the successive injec-
tions of OxyHb at five progressively higher concentrations, ranging from 0.01 to 1 µM, on a IsdB-functionalized 
chip, are shown in Fig. 3A (black curves). The response signal increased after every injection and reached a steady 
state value before the end of each injection, indicating the formation of the IsdB:OxyHb complex. Subsequently, 
the buffer was flowed over the ligand and the response signal decreased, indicating the dissociation of Hb. A 1:1 
model was used to fit the data and to extract the kinetic parameters for the IsdB:OxyHb interaction (Fig. 3A, 
red curve, and Table 2). Fitting to a two-state model with either a reversible or irreversible second step does not 
improve the fitting significantly (data not shown).
It has been suggested that IsdB13,28 could show preferences in binding to either α or β chains of Hb. This 
observation has critical consequences not only on the mechanistic description of complex formation, but also 
on the design of protein-protein interaction (PPI) inhibitors tackling the complex stability. For a direct study 
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of any chain preferences we decided to use semiHbs, α/β heme molecule for each dimer at either the α or β 
subunit, hence any difference in the binding and extraction process can be directly attributed to one specific 
subunit. Figure 3B shows the sensorgram obtained by injecting five increasing concentrations of α-semiOxyHb 
over the wt IsdB-functionalized substrate. The response signal increases after every injection, witnessing the 
formation of the IsdB:α-semiOxyHb complex. Then, the buffer injection causes the partial dissociation of the 
complex. Fitting to a 1:1 model gives a good description of experimental data (chi square = 1.22; Table 2). Similar 
results were obtained with β-semiOxyHb (Fig. 3C, chi square = 2.85; Table 2). Interestingly, α-semiOxyHb and 
Figure 2. Spectroscopic characterization of heme extraction from Hb and semiHb by wt IsdB and IsdBY440A. 
(A) Absorption spectra of 1.5 µM MetHb before (brown) and after (green) mixing with 7.5 µM IsdB. Inset: 
time-dependence of absorbance at 406 nm upon mixing IsdB with OxyHb (red) or MetHb (brown). (B) 
Stoichiometric titration of MetHb with IsdB. (C) Absorption spectra of 1.5 µM MetHb before (brown) and after 
(orange) mixing with 7.5 µM IsdBY440A. Inset: time-dependence of absorbance at 406 nm upon mixing IsdBY440A 
with MetHb. (D) Absorption spectra of 1.5 µM α-semiHb (dark blue) or β-semiHb (pink) before (continuous 
line) and after (dashed line) mixing with 7.5 µM IsdB. Inset: time-dependence of absorbance at 406 nm upon 
mixing IsdB with α-semiHb (dark blue) or β-semiHb (pink). Black lines through kinetic traces are the fitting to 
a biexponential equation with parameters reported in Table 1.
IsdB-Hb complex k1 (s−1) Amp1 (%) k2 (s−1) Amp2 (%)
IsdB-MetHb 0.20 ± 0.01 67 0.053 ± 0.001 33
IsdB-α-semiMetHb 0.29 ± 0.01 88 0.039 ± 0.001 12
IsdB-β-semiMetHb 0.27 ± 0.01 84 0.037 ± 0.001 16
IsdBY440A-MetHb 0.22 ± 0.01 95 0.017 ± 0.001 5
Table 1. Observed rate constants and relative amplitudes obtained by fitting single-wavelength UV-Vis kinetics 
with a biexponential equation.
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β-semiOxyHb show very similar microscopic rate constants and calculated Kd, suggesting that IsdB is able to 
bind equally well the two globin chains. The same single-cycle kinetics SPR approach described above for the 
OxyHbs was used to study the interaction between IsdB and MetHb or semiHbs in the oxidized form. Figure 3D 
Figure 3. SPR sensorgrams (black curves) of the response (Resonance Units, RU) versus time of the single-
cycle kinetics performed by injecting five increasing concentrations (0.01, 0.05, 0.1, 0.5, 1 µM) of Hb over the 
IsdB-functionalized substrate. The red curves are the fitting with either a 1:1 or a two state irreversible binding 
model. Fitting parameters are reported in Table 2. The resulting kinetic parameters are reported in Table 2. 
(A) IsdB-OxyHb (1:1) (B) IsdB-α-semiOxyHb (1:1) (C) IsdB-β-semiOxyHb (1:1) (D) IsdB-MetHb (two-state 
irreversible) (E) IsdB-α-semiMetHb (two-state irreversible) (F) IsdB-β-semiMetHb (two-state irreversible) (G) 
IsdBY440A-OxyHb (1:1) (H) IsdBY440A-MetHb (two-state irreversible).
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shows the sensorgram obtained by injecting five increasing concentrations of MetHb over the IsdB functionalized 
substrate. The sensorgrams were best fitted by using a two-state irreversible model (red line). The same fitting 
model was used to fit binding data with α-semiHb and β-semiHb in the MetHb form (Fig. 3E,F, respectively); the 
corresponding parameters are reported in Table 2. The complex formation is significantly faster for MetHb, which 
also dissociates faster from IsdB with respect to OxyHb. Despite the different microscopic kinetic constants, the 
resulting affinity of the complex is similar when either OxyHb or MetHb are used. In the model proposed, the 
first step, corresponding to the encounter complex formation, is followed by a second, irreversible step. As for 
the wild type protein, the binding kinetics of the IsdBY440A variant were analyzed using a 1:1 model for OxyHb 
and a two-step irreversible or reversible model for MetHb. The latter possibility was taken into account because, 
given the inability of the IsdBY440A mutant to complete the heme transfer, heme extraction and accompanying 
conformational changes could in principle be reversible. Sensorgrams are shown in Fig. 3G, H for OxyHb or 
MetHb binding to IsdBY440A mutant, respectively. Fitting with a 1:1 model of OxyHb binding to IsdBY440A results 
in kinetic parameters very similar to those obtained for wt IsdB (Table 2), demonstrating that the mutation does 
not affect the complex formation. Interestingly, both two-step reversible and two-step irreversible models were 
able to properly fit the experimental data obtained for MetHb. The two-step reversible model gives a very slow 
off rate for the second step, thus making this event virtually irreversible. As a matter of fact, the on rate for the 
second step (data not shown) is comparable to the one calculated with the two-step irreversible model that was 
thus chosen to fit the data.
Molecular simulations. Suitable models for simulating the IsdB:Hb interaction (Figs. 1 and 4) were assem-
bled using the unique available co-crystallized complex (PDB code 5vmm), recently reported by Bowden et al.13, 
where two IsdB molecules bind the α chains of a Hb tetramer, while the β chains are bound by a single N1 
domain. Other structures reporting complexes of IsdH with Hb present the IsdH monomer, or the only N1, 
bound to one Hb dimer by means of the α chain (PDB code 4xs0 and 4fc3, respectively), or four IsdH bound 
to a Hb tetramer, in agreement with a 1:1 stoichiometry (PDB code 4ij2). To limit the modelling we decided to 
perform our simulations on the unique complete assembly, formed by one IsdB monomer and one Hb dimer.
In the 5vmm structure, the heme occupies an intermediate position between IsdB and Hb and the α chain 
helix F is partially unfolded. To properly simulate the initial encounter complex we replaced Hb by either MetHb 
or OxyHb structures (PDB code 3p5q and 2dn1, respectively; see Materials and Methods for further details). 
As mentioned, IsdB is formed by two NEAT domains, with N1 involved in Hb recognition, and N2 in heme 
extraction. The two are connected by a α-helix-based linker (IsdBL; Fig. 1). All elements interact with Hb α 
chain, at a different extent. The following systems, modelled as described in Fig. 4, were prepared and submit-
ted to 1 μs molecular dynamics (MD) simulations (Fig. S4): MetHb, IsdB:αβMetHb, holoIsdB:apoαβMetHb, 
IsdB:αβOxyHb, IsdBY440A:αβMetHb and IsdB:βαMetHb. Each complex was carefully investigated to identify the 
crucial residues involved in the complex formation and, possibly, in the heme extraction. The occupancy of the 
hydrogen bonds, as identified by Gromacs, formed at the IsdBN1-Hb, IsdBL-Hb and IsdBN2-Hb interfaces was 
traced along the MD trajectories and is reported in Fig. 5, along with the corresponding involved residues. Only 
contacts showing an average occupancy higher than 20% in one of the analyzed models have been considered 
relevant for the analysis.
IsdB:αβMetHb. The most conserved contact (number 3) at the IsdBN1:Hb interface is formed by Lys11Hb and 
the carbonyl oxygen of Ala168IsdB. This contact shows an occupancy close to 70% in all the analyzed models, 
i.e. IsdB:αβMetHb, holoIsdB:apoαβMetHb and IsdB:αβOxyHb. Other crucial contacts in IsdB:αβMetHb model 
are number 1, 2, 4 and 9, all having an occupancy close or higher than 40% (Fig. 5.1). Overall, the key residues 
involved are Thr8Hb, Asn9Hb, Lys11Hb, Ala71Hb, Asp74Hb, Thr118Hb, Ala168IsdB, Lys172IsdB, Ser191IsdB, Tyr220IsdB 
and Asn243IsdB (Fig. 5.2A).
At the IsdBL:Hb interface we observed the formation of a salt bridge between Asp85Hb and Arg290IsdB 
(Fig. 5.2B), while at IsdBN2:Hb interface several H-bonds are maintained along the simulation, involving Thr41Hb, 
Lys60Hb, Lys61Hb, Arg92Hb, Glu357IsdB, Thr437IsdB and Asp439IsdB (Fig. 5.2C). This complex interaction pattern 
might properly prepare the system for the transfer of the heme, which interacts with His45Hb, His58Hb, Tyr440IsdB 
and Tyr444IsdB (Table S1, Fig. 6A). These last two residues are likely involved in pulling the heme out of its binding 
pocket. However, in this and in the following simulations, no significant translation of the heme can be observed.
IsdB-Hb complex
kon(1) 
(103 M−1s−1)
koff(1) 
(10−3 s−1)
kon(2) 
(10−3 s−1) KD (nM) Rmax χ2
IsdB-OxyHb 8.1 ± 0.1 0.83 ± 0.02 102 ± 3 10.43 0.27
IsdB-α-semiOxyHb 44 ± 1 1.93 ± 0.05 44 ± 2 9.85 1.22
IsdB-β-semiOxyHb 77 ± 2 2.0 ± 0.1 26 ± 1 12.35 2.85
IsdB-MetHb 530 ± 40 37 ± 1 1.21 ± 0.03 70 ± 6 11.8 1.09
IsdB-α-semiMetHb 130 ± 10 14 ± 1 1.51 ± 0.03 108 ± 11 52 10.90
IsdB-β-semiMetHb 54 ± 2 4.9 ± 0.2 1.21 ± 0.03 91 ± 5 42.7 3.36
IsdBY440A-OxyHb 9.7 ± 0.1 1.2 ± 0.1 124 ± 10 5.3 0.12
IsdBY440A-MetHb 53 ± 1 5.1 ± 0.2 0.97 ± 0.02 96 ± 4 16.6 0.94
Table 2. Microscopic kinetic constants and dissociation constants calculated by SPR.
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holoIsdB:apoαβMetHb. We performed the same analyses on the holoIsdB:apoαβMetHb model, which should 
represent the final step of the IsdB:Hb interaction, upon the heme transfer. We have to consider that, if Hb is 
released by IsdB once the heme transfer has occurred, this state could represent a poorly populated species (see 
discussion). Even so, we decided to model this state to have indications about the rearrangement of the complex 
interface.
The IsdBN1:Hb (Fig. 5.2D) and IsdBL:Hb (Fig. 5.2E) interfaces are quite similar to those described above for 
IsdB:αβMetHb, while the IsdBN2:Hb line significantly differs (Fig. 5.2F). In particular, contacts involving Gln54Hb 
and Ser361IsdB, His45Hb backbone and Thr365IsdB, Ala53Hb and Asn359IsdB (contacts number 24, 25 and 26, respec-
tively) are formed and maintained.
With respect to IsdB:αβMetHb, the propionates of the heme, now located in the IsdB binding site, still interact 
with His45Hb and His58Hb on Hb, and with Ser361IsdB and Met362IsdB (as already reported in22) on IsdB (Table S1, 
Fig. 6B).
Figure 4. Models assembly for molecular modelling. The original X-ray structures and the corresponding PDB 
codes are reported on the left.
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Figure 5. High-occupancy hydrogen bonds in IsdB:Hb. (1) Relevant polar contacts at IsdB:αβHb interface and 
relative hydrogen bond occupancy during MD simulations. Each polar contact is given an ID number. Donor-
acceptor pairs having an occupancy higher than 20% are reported for each MD simulation and compared 
with the same pairs in all the other simulations. Polar contacts were subdivided according to their localization 
(IsdBN1-Hb, IsdBL-Hb, IsdBN2-Hb interfaces, respectively). (2) High occupancy polar contacts at the IsdB:αβHb 
interface for IsdB:αβMetHb (pink), holoIsdB:apoαβMetHb (light blue), IsdB:αβOxyHb (light orange), 
IsdBY440A:αβMetHb (grey) simulations, respectively. Polar contacts are shown as dashed black lines, highlighted 
in yellow and numbered in bold, according to their ID number in Panel 1. Donor-acceptor pairs are depicted 
in sticks and labelled in black (IsdB residues) and in red (Hb residues). The heme group (green) is represented 
in spheres and sticks. (3) Comparison of the H-bond occupancy profile at the interface of the complexes 
IsdB:αβMetHb and holoIsdB:apoαβMetHb (A); pink and light blue line, respectively), IsdB:αβMetHb and 
IsdB:αβOxyHb (B); pink and orange line, respectively), IsdB:αβMetHb and IsdBY440A:αβMetHb (C); pink 
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IsdB:αβOxyHb. The H-bond pattern at the IsdB:αβOxyHb interface is still quite different from IsdB:αβMetHb. 
We have to remember that the dissociation constant for the two complexes is similar (100 ± 10 nM and 69 ± 1 nM, 
respectively. See Table 2), but the heme cannot be extracted from OxyHb. At the IsdBN1:Hb level six contacts 
maintain an occupancy higher than 20%, with the most relevant being formed by Asp74Hb and Tyr220IsdB, Lys11Hb 
and Ala168IsdB, Thr8Hb and Ser191IsdB (Fig. 5.2G). At the IsdBL:Hb interface the Asp85Hb-Arg290IsdB contact 
observed in IsdB:αβMetHb and conserved in holoIsdB:apoαβMetHb, is lost and replaced by Asp85Hb-Tyr293IsdB 
and Asp85Hb-Lys297IsdB interactions (Fig. 5.2H). Finally, at the IsdBN2:Hb line, the highest occupancy contacts 
are Gln54Hb-Ser361IsdB and Ala53Hb-Asn359IsdB(number 24 and 26, respectively. Fig. 5.2I). Interestingly, the heme 
strongly interacts with Arg290IsdB, previously involved in stabilizing the IsdBL:Hb interface, while the contacts 
with His45Hb, Tyr440IsdB and Tyr444IsdB, even if still present, are less conserved, possibly disrupting the proper 
residue arrangement for heme extraction (Table S1 and Fig. 6C).
IsdBY440A:αβMetHb. The IsdBN1:Hb interface of the Y440A mutant presents a similar profile to that of 
IsdB:αβMetHb (Fig. 5.1, 5.2L). A comparable number of interactions is maintained, as well as the crucial residues 
involved. The IsdBL:Hb interface presents a single contact involving Lys90Hb and Glu289IsdB, thus being less stable 
than in the previous cases (Fig. 5.2M), in which a salt bridge or multiple contacts were formed, as also confirmed 
by the following ED analysis. At the IsdBN2:Hb line, while a number of interactions are maintained as in the wild 
type complex, additional contacts appear, e.g. His45Hb-Tyr444IsdB and Gln54Hb-Tyr391IsdB (Fig. 5.2N). The heme 
also maintains a weak interaction with His45Hb and a more stable one with Tyr444IsdB, while the two residues are 
not involved in interacting one with each other (Table S1, Fig. 6D).
In Fig. 5.3 we have compared the H-bond occupancy profile of the IsdB:αβMetHb complex with that of holo-
IsdB:apoαβMetHb (Fig. 5.3A), IsdB:αβOxyHb (Fig. 5.3B) and IsdBY440A:αβMetHb (Fig. 5.3C). Interestingly, with 
a few exceptions, the trend at the IsdBN1-Hb level is rather maintained. This confirms the role played by the 
aforementioned residues and suggests that, regardless the ability to complete heme transfer, the key interactions 
are maintained.
The contacts at the IsdBL-Hb line are much more variable. While the profile is maintained in both 
IsdB:αβMetHb and holoIsdB:apoαβMetHb (Fig. 5.3A), in the IsdB:αβOxyHb and IsdBY440A:αβMetHb cases dif-
ferent residues play key roles in contact formation (Fig. 5.3B,C respectively).
At the IsdBN2-Hb interface the pattern presented by IsdB:αβMetHb cannot be reproduced by any of the other 
complexes. The only conserved contact (number 19) involves Glu354IsdB and Lys61Hb, also maintained in the 
IsdB:βαMetHb model (number 13, Fig. 5.4). The profile of holoIsdB:apoαβMetHb is, instead, similar to that 
shown by IsdB:αβOxyHb. In both cases, the heme cannot be extracted and contacts between Met362IsdB and 
Thr365IsdB with Gln54Hb, or Thr437IsdB:Thr41Hb and Asp439IsdB:Arg92Hb are lost. The IsdBY440A:αβMetHb profile 
is slightly more similar to that of IsdB:αβMetHb, at least in the first part, while additional interactions are formed 
by the residues at the IsdB carboxylic terminal. We should remember that the mutated IsdB is not able to complete 
the heme extraction22. The only contact maintained in all the simulations involves His45Hb, while heme extraction 
is mainly assisted by Tyr440IsdB and Tyr444IsdB, highlighting their role in pulling the heme out of its binding site 
(Fig. 6).
IsdB:βαMetHb. Kinetic data indicate that the dissociation constants for the first reversible binding step of IsdB 
to Hb are similar when calculated with α-semiHb and β-semiHb, suggesting a similar binding of IsdB to both 
α and β chains (Table 2). To further investigate α/β selectivity, we modelled an IsdB:Hb complex in which Hb 
chains are inverted and the IsdB directly binds to the β chain (IsdB:βαMetHb, Fig. 4). The H-bond occupancy 
analysis showed that similar contacts are maintained with respect to the IsdB:αβMetHb complex (Fig. 5.4). The 
most relevant at the IsdBN1:Hb interface are Asp79Hb:Tyr220IsdB, Glu121Hb:Lys245IsdB, Glu121Hb:Asn243IsdB, 
Lys17Hb:Glu247IsdB (also conserved in IsdB:αβMetHb), Lys8Hb:Gln190IsdB and Asp73Hb:Tyr167IsdB (Fig. 5.5A). 
The IsdBL:Hb interface is stabilized by additional interactions in which Glu90Hb, corresponding to Asp85Hb in 
the α chain, contacts Tyr293IsdB and Lys297IsdB (Fig. 5.5B). Finally, at the IsdBN2:Hb line we can observe the 
Lys65Hb:Glu357IsdB and Lys66Hb:Glu354IsdB contacts, also present at the IsdB:αβMetHb interface, the addi-
tional Arg40Hb:Thr437IsdB and those involving Lys59Hb, interacting with Glu360IsdB, Ser361IsdB and Asp364IsdbB 
(Fig. 5.5C). The heme propionates are weakly coordinated by His63Hb and Tyr440IsdB and more constantly by 
Tyr444IsdB (Table S1, Fig. 6E). These findings further support the capability of IsdB to similarly interact with both 
Hb chains and to, consequently, extract the heme.
To get insights about the complex intrinsic flexibility we analyzed all MD trajectories by means of Essential 
Dynamics (ED), able to identify the essential motions of the protein backbone. The well-known flexible C/E and 
C/D loops in Hb α chain and β chain36, respectively, were removed from the ED analyses to not bias the iden-
tification of other dynamic elements. In all complexes, the ED was carried out separately for each individual α 
and β globin chain, for the αβ dimer (Hb) and for IsdB. Eigenvectors were then sorted out in decreasing order 
depending on their corresponding eigenvalues, which have been reported in Table S2. In Fig. 7 we graphically 
represented the projection of the trajectory on the first eigenvalue, responsible for the highest structural variation.
and grey line, respectively). H-bonds are indicated by numbers according to 5.1. (4) Relevant polar contacts at 
IsdB:βαMetHb interface and relative hydrogen bond occupancy during MD simulations. Polar contacts with 
an occupancy higher than 20% are reported, each pair is given an ID number. (5) View of polar contacts at the 
IsdB:βαMetHb interface; each hydrogen bond is shown as a dashed line, highlighted in yellow and labelled 
according to the ID number in Panel 4. Hb residues are tagged in red, while IsdB residues are tagged in black.
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We chose as reference MetHb, whose ED shows a quite stable structure, with the highest flexibility localized at 
the terminal region of helix F and at the E/F loop of chain β, being notably more flexible than α chain36 (Fig. 7A). 
Hb dynamics increases upon binding of IsdB, in particular at the β chain level, in agreement with its higher flex-
ibility and with the constraint exerted by IsdB on α chain (IsdB:αβMetHb complex, Fig. 7B). IsdB shows, as well, 
a significant level of flexibility in the two NEAT domains and a little less in the linker section. When the heme 
has been already transferred to IsdB, the entire complex flexibility decreases, with the only exception of the IsdB 
linker (holoIsdB:apoαβMetHb, Fig. 7C). Indeed, the first eigenvector for IsdB mostly regulates the flexibility 
of the tether between N1 and N2. In the IsdB:αβOxyHb complex the IsdB dynamics increases (first eigenvalue 
equal to 12,4 nm2, Table S2), in particular at N2 domain level (Fig. 7D). Analogously, a high plasticity of N2 can 
be observed for IsdBY440A:αβMetHb (first eigenvalue for IsdB equal to 18.3 nm2), in which the heme extraction is 
not complete. As well, the linker shows the highest flexibility, according to the projection on the first eigenvector 
(Fig. 7E, Table S2). Finally, in the IsdB:βαMetHb (Fig. 7F) complex the IsdB linker and N2 domain show a flex-
ibility level similar to that observed for IsdB:αβMetHb, while the N1 domain seems quite disordered. The plots 
reporting the trajectory projection on the first two eigenvectors, defined as the essential space, are reported in 
Fig. S5.
To further investigate the system dynamics, we calculated the cosine content for the first eigenvector (ci; 
Table S3), giving indications about the possible functional main movements far from random diffusion. Overall, 
the hemoglobin dimer (Hb) shows a high ci (e.g. non-functional movements) in IsdBY440A:αβMetHb and in 
IsdB:αβOxyHb complexes, where IsdB is defective or is unable to conclude the heme extraction. Similarly, the ci 
is high for the Hb in MetHb, consistently with the absence of the hemophore.
Even more interestingly, the ED shed light on structural rearrangements (ci ≤ 0.1) on IsdB taking place in 
complexes where the heme transfer is hindered. Specifically, in holoIsdB:apoαβMetHb and IsdBY440A:αβMetHb, 
where the heme transfer already occurred or will not be completed, the first eigenvector indicates a massive 
motion involving the linker domain, pulling it away from hemoglobin. Correspondingly, in IsdB:αβOxyHb, 
where the extraction cannot be performed, the linker slides down towards the IsdBN2 domain. On the other hand, 
no such motions have been registered in IsdB:αβMetHb and in IsdB:βαMetHb, for which the high cosine content 
reflects the absence of large non-equilibrium transitions (Fig. S6).
Discussion
Heme acquisition by pathogens using specialized receptors and membrane transporters has attracted much atten-
tion since this constitutes a relevant process for bacterial physiology and virulence and, therefore, a potential 
promising site of therapeutic intervention. Although many reports demonstrate the larger relevance of IsdB in 
supporting S. aureus iron demand during infection, the IsdB system is far less characterized than IsdH, limiting 
the understanding of the reasons for redundancy of these Hb receptors and, eventually, the possibility to envisage 
approaches for interfering with complex formation.
IsdB purified from E. coli recombinant systems contains a variable fraction of heme bound, ranging from 1 
to 30%, depending on the strain used for the expression, the expression yields and the growth conditions37. The 
fraction of holoIsdB present in the IsdB preparations used to study the interaction with Hb and heme extraction 
is rarely mentioned and quantified. The knowledge of the fraction of heme in the starting preparation is rele-
vant, since it might affect Hb binding and introduce artifacts in the calculation of affinity and/or heme transfer 
efficiency. The amount of holoIsdB in all the preparations used in this study was calculated on the basis of the 
Figure 6. Polar contacts made by the heme with the IsdB and Hb residues for the analyzed complexes. (A) 
IsdB:αβMetHb. (B) HoloIsdB:apoαβMetHb. (C) IsdB:αβOxyHb. (D) IsdBY440A:αβMetHb. (E) IsdB:βαMetHb. 
Hydrogen bonds are shown as dashed lines, Hb residues are labeled in red, while IsdB residues are labeled in 
black.
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extinction coefficient of the Soret band and is consistently lower than 5%. The low amount of heme-saturated IsdB 
obtained from bacterial cultures grown in rich medium depends on the high expression yields of this expression 
system and the limiting heme availability in E. coli. The negligible amount of holoIsdB in the preparation and 
hence the knowledge of the exact apo-protein concentration allowed to accurately calculate the stoichiometry of 
Hb binding to IsdB in solution. Such stoichiometric ratio is 1, i.e. each Hb monomer binds one IsdB molecule. A 
further point that needed to be addressed before starting any mechanistic and kinetic investigation of complex 
formation and heme extraction process is the oligomeric state of Hb under our experimental conditions. It is well 
assessed that human Hb is a stable tetramer only in concentrated solutions, like those found inside the eryth-
rocytes, and that once the concentration drops to the low micromolar range a mixture of dimers and tetramers 
is present. Dimers are stable down to low nM concentrations, when monomerization occurs. Relevant for the 
current study, the quaternary state of Hb affects the rate of spontaneous heme release38. We calculated a KD for 
the tetramer/dimer equilibrium of 0.25 ± 0.05 µM for OxyHb and 0.52 ± 0.06 µM for MetHb (Fig. S2). Therefore, 
under the conditions used for the stoichiometric titration, Hb is expected to be 90% in the tetrameric form, 
which might cause steric hindrance in binding of four IsdB molecules13. However, it is conceivable that, as already 
reported for IsdHN2N328, IsdB binding promotes Hb dimerization and that the dominant form of the complex is 
that where two IsdB chains are bound for each Hb dimer. As mentioned, the 1:1 stoichiometry agrees with the 
published IsdB:MetHb complex, where the Hb tetramer is bound to two full-length IsdB chains and two isolated 
N1 domains, likely generated by proteolysis during crystallization13. A similar stoichiometry (3.5 hemophore 
chains per Hb tetramer) was observed for the IsdH:MetHb system published by Dickson et al. in 2014 (PDB code 
4ij2)27.
In the concentration range used for SPR experiments Hb is mainly dimeric, from 98% at 0.01 μM to 35% at 
1 μM. These experimental conditions also span the physiological range usually observed for extracellular Hb, 
falling in the low micromolar range. The models used to fit SPR data were chosen on parsimony basis and are 
consistent with previous reports on similar systems39. The two-step model used for MetHb allows to separate the 
contributions to the overall process of the bimolecular binding step and the following event(s). The bimolecular 
rate of complex formation with IsdB is consistently higher for MetHb than OxyHb. However, the encounter com-
plex also dissociates faster, and thus the resulting affinity is similar for OxyHb and MetHb. The kinetic control of 
protein-protein association is a well-assessed strategy to achieve interaction specificity, for example in the case of 
different proteins competing for the same receptor40. In the case of IsdB the faster association rate with MetHb 
compared to OxyHb might be suggestive of some kinetic bias for complex formation with the productive species.
Of notice, the KD for bimolecular complex formation is similar when binding occurs at the α or β subunits, 
i.e. when α- and β-semiHb are used. This unambiguously supports the view that IsdB does not show any chain 
preference in binding to Hb. The equivalence of α and β subunits for IsdB binding has already been described 
in previous reports that, however, exploited less direct approaches, i.e. the observation of mono-exponential 
heme-transfer kinetics or the analogy with IsdH13,24–26,28,41. SPR has already been applied for determining the 
affinity of S. aureus hemophores to Hb; however, data analysis was limited to the thermodynamics of complex 
formation, with no kinetic insight. The dissociation constants reported for IsdH12,33,42 and IsdB12,37 fall in the 
nanomolar range independently from the chip architecture and the immobilization tags and are thus comparable 
to those found in this report12,33. With MetHb, the encounter complex formation is followed by a slow, irreversible 
step. This step might be attributed to heme transfer and/or an associated, rate-limiting conformational change 
of the protein. However, if the kon for the second step is compared with the kobs obtained by UV-Vis absorption 
Figure 7. Extreme trajectory conformations projected along the first eigenvector.
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spectroscopy (Fig. 2) or with published data13,20,24,31,34, it is 2-order of magnitude slower. Indeed, the calculated 
rate is comparable to or slightly faster than the rate of spontaneous release of heme from Hb depending on the 
subunit and the oligomeric state considered38. This is apparently in contrast with other reports, where a “catalyst” 
role was attributed to IsdB and other proteins involved in heme transfer from Hb to the bacterial cell20,31. That 
assumption was based on the observation that, in the presence of IsdB, heme is transferred from Hb to IsdA 
100-fold faster with respect to spontaneous heme release20. However, it should be noted that our experiments 
were carried out in the absence of an acceptor molecule (i.e.: IsdA). Our results suggest that the rate limiting step 
in the absence of a heme acceptor like IsdA is not heme transfer (rate-limited by a still poorly defined Hb struc-
tural isomerization), but IsdB:Hb complex dissociation:
A slow phase also characterizes the association of Hb with IsdBY440A, a mutant missing a key residue for heme 
coordination. Consistently with the observed time-dependence of spectroscopic variations (Fig. 2C, inset), this 
Figure 8. Torsion angles in F helix. Phi (ϕ) and psi (ψ) torsion angles of helix F were measured for each frame 
of the trajectories. Each measurement is represented as a black dot with coordinates (ϕ, ψ), and scatter plotted 
against the Ramachandran plot (blue contour for general, pink for pre-proline, green for proline, yellow for 
glycine residues, respectively). (A) Torsion angles of α chain F helix in αβMetHb. (A’) Torsion angles of α 
chain F helix in IsdB:αβMetHb. (B) Torsion angles of β chain F helix in αβMetHb. (B’) Torsion angles of β 
chain F helix in IsdB:βαMetHb. Ramachandran plots were generated in MATLAB 2019a from a dataset of 
high-resolution X-ray structures by Lovell et al.71, torsion angles were calculated with the g_rama_mpi function 
implemented in GROMACS ver. 4.6.1.
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mutant is able to initiate heme extraction from Hb, likely the trigger for complex dissociation, but appears unable 
to complete heme transfer.
Extensive molecular simulations were carried out to gain structural resolution both on PPI and the following 
dynamics. The composite pattern of electrostatic interactions that we observed might provide the IsdB:αβMetHb 
complex with the sufficient stability at the IsdBN1:Hb interface to allow the N2 domain approaching the heme 
binding site and starting the extraction process. Specific key residues on Hb and on the three IsdB domains (N1, 
N2 and the linker region) can be identified and retained relevant for the process. At the IsdB N1 level, Ala168IsdB, 
Lys172IsdB, Ser191IsdB, Tyr220IsdB, Asn243IsdB seem implicated in the stabilization of the, likely, first interac-
tion between IsdB and Hb. As well, crucial residues on Hb are Thr8Hb, Asn9Hb, Lys11Hb, Ala71Hb, Asp74Hb and 
Thr118Hb. The role of Thr8Hb, Lys11Hb and Asp74Hb has been already highlighted in previous works by Dickson 
et al.27 and Pishchany et al.15 Also, Choby and co-workers recently reported that the Thr8Lys mutation reduces 
the binding by S. aureus and that the N-terminal helix of Hb α chain gives a significant contribution to the 
human-specific Hb recognition by the bacterium43. In our simulation Asn9Hb is involved in contacting Gln243IsdB 
in all but the IsdB:αβOxyHb complex. The Asn9His mutation has been also found responsible for a decreased 
binding. On the IsdB side, the Gln162-Ser170 region (loop 2) in N1 domain has been proved critical for Hb 
binding15,20,25,41,43 and it contains the Hb-binding motif. We specifically recognized the importance of Ala168IsdB 
in contacting Lys11Hb at the level of IsdBN1-αHb interface, and of Tyr167IsdB, interacting with Asp73Hb at the 
IsdBN1-βHb interface. Other residues retained particularly relevant for the complex formations, as Phe164IsdB 
and Tyr165IsdB, could be involved in forming hydrophobic interactions with Hb and, mostly, in stabilizing the 
helix conformation of the loop, fundamental for Hb recognition and binding25. While disordered in solution, 
the loop 2 assumes, in fact, a stable helix conformation in X-ray structures, according to a folding-upon-binding 
model, often observed for intrinsically disordered protein regions25,44. The IsdB linker is also involved in signif-
icant interactions with Hb, as previously mentioned, and also highlighted by Fonner et al., who found that the 
linker domain increases the affinity of IsdBN1 for MetHb and that it accelerates the heme transfer when com-
bined with IsdBN225. Our simulations identified Arg290IsdB-Asp85Hb as crucial contact for the stabilization of the 
IsdB:αβMetHb complex and Tyr293IsdB-Glu90Hb and Lys297IsdB-Glu90Hb for the IsdB:βαMetHb one. The most 
relevant residues involved in the heme extraction at the IsdBN2:αHb interface appear to be, definitely, Tyr440IsdB 
and Tyr444IsdB, both involved in pulling the heme out of the Hb binding site and in stabilizing it in the IsdB 
pocket. The inability of the IsdBY440A mutant to complete the heme extraction, as well as crystallographic evi-
dences22 clearly supports the data previously reported in literature13,22. Our simulations found in Tyr444IsdB a key 
residue for heme binding, with an occupancy of the H-bonds between the residue side chain and the heme propi-
onates of about 40% (Table S1). Interestingly, His45Hb has been also found relevant in contacting the heme in all 
the simulations, suggesting to have a relevant role in holding the cofactor and accompanying its transfer from Hb 
to IsdB. Once in IsdB binding site, the heme is then stabilized by Ser361IsdB, as also found in the transient IsdB:Hb 
complex13 and in the sole IsdB NEAT2 structure22. The stabilization of the IsdBN2:αHb is mainly achieved by 
Arg31Hb, Ser44Hb, Lys59Hb, Lys66Hb on Hb α chain and, on IsdB, by Glu354IsdB, Glu357IsdB, Met362IsdB, Thr365IsdB, 
Thr437IsdB, Asp439IsdB, often involved in contacting also the β chain, according to our simulations (Fig. 5). None 
of the IsdB mentioned residues has been found mutated in a set of 3277 S. aureus strains taken from the NCBI 
SRA database, thus confirming their relevance for a stable Hb binding15, and the possibility to be targeted in the 
search for PPIs inhibitors.
With respect to the MetHb by itself, all the inspected complexes showed a more flexible Hb. The only excep-
tion is represented by the IsdB:αβOxyHb complex, in agreement with the faster microscopic kinetic constants 
calculated through SPR experiments for MetHb with respect to OxyHb. Interestingly, the dynamics of chain β 
significantly exceeds that of chain α in all the cases. Previous laser flash photolysis experiments reported the 
capability of the β subunit, with respect to the α one, to faster release small ligands45,46, with a possible implication 
of a different intrinsic dynamics. Furthermore, the diverse flexibility of α and β chains is also reflected in very 
different rates of spontaneous heme release from Hb, with β of spontaneous heme release from Hb, with β chains 
releasing it about 50-fold fastere than α chains. The higher degree of β flexibility is already visible in MetHb alone 
(Fig. 7A). The retention of this asymmetry upon IsdB binding suggests that the whole process of binding and 
heme extraction is unaffected by intrinsic difference in globin chain dynamics. This is in line with the observation 
that IsdB has a catalytic effect on heme release from Hb and that this effect overwhelms any heterogeneity in the 
rate of spontaneous release.
The step of heme extraction (about 0.3 s−1)13,20 seems to be represented by a large, irreversible conformational 
change not yet thoroughly characterized. We might argue that the increased flexibility of Hb observed along the 
MD simulations could correspond to the first step of this conformational adjustment, facilitating the heme scav-
enging. The latter could be also promoted by the complete or partial unfolding of helix F, and by the consequent 
weakening of the coordination bond between the heme iron and the proximal histidine. Even if no breakage of 
the coordination bond can be observed with such plain MD simulations, the helix undergoes a partial destabi-
lization in both IsdB:αβMetHb and IsdB:βαMetHb models, with respect to single MetHb. This can be clearly 
appreciated by the decreased occupancy of intra-chain H-bonds reported in Fig. S7, and by the change in the 
ϕ/ψ torsional angle distribution observed upon the binding of the hemophore shown in Fig. 8. In both cases, 
the Ramachandran plot of the residues forming the helix present a change of the dihedrals distribution for the 
proximal histidine (His87 in α chain and His92 in β chain), the residues close the histidine and, in particular for 
the β chain, for the amino-terminal of the helix. This structural destabilization, induced by IsdB that pulls Hb 
helix F by means of Arg290IsdB, located in the linker region, has already been pointed out13. Here, a further level of 
detail is added and our results point to larger conformational changes involving both proteins. The ED analyses 
also highlighted the overall flexibility of IsdB and the importance of the linker in regulating the communica-
tion between the two NEAT domains (Fig. S6, Table S3). As suggested by the cosine content calculation, IsdB 
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undergoes anharmonic motions, specifically located at the linker level, when the heme extraction process cannot 
be completed or has already happened and the entire IsdB has, reasonably, to detach from the Hb.
conclusions
We investigated by spectroscopic and analytical methods several aspects of IsdB:Hb complex formation that 
remained elusive so far, and that could be key to the design and selection of specific PPI inhibitors with a potential 
as innovative antimicrobials. Molecular modelling and essential dynamics were exploited to gain structural res-
olution, often missing or controversial, on PPI interfaces and the dynamics triggered by complex formation and 
leading, with MetHb but not with OxyHb, to heme extraction and transfer to IsdB. In particular, by exploiting the 
semiHb variants, we unequivocally demonstrated that the hemophore does not exert any selectivity in binding 
and extracting heme from the α or β subunit of human Hb. This is also highlighted by MD simulations and essen-
tial dynamics analysis, which showed the persistence of similar contacts at the IsdB:αβMetHb and IsdB:βαMetHb 
interface, and a similar level of flexibility at the IsdB linker and N2 domain. Consistently, any Hb intradimer 
communication following binding to the hemophore, as detected by essential dynamics, does not elicits coop-
erativity in Hb:hemophore binding, while could perhaps be relevant in promoting Hb monomerization. Also, 
microscopic kinetic rates were determined for IsdB binding to the α and β subunits of Hb, either in the oxidized 
form, the dominant one in the plasma under infection conditions in vivo, or in the reduced, oxygenated state. 
Spectroscopic, SPR and computational results are consistent with a model where formation of an IsdB:MetHb 
encounter complex is followed by heme extraction, structural strain in Hb liganded subunits, heme transfer to 
IsdB and a slow release of apoHb from holoIsdB. In the absence of a final acceptor of heme, such as IsdA, the 
whole process is limited by the slow release of apoHb from the complex with IsdB.
Materials and Methods
Reagents and solutions. Chemicals were purchased from Merck and Applichem if not otherwise stated. 
Reagents were used as received. The experiments were carried out in reaction buffer, Tris/HCl 100 mM, NaCl 
150 mM, EDTA 1 mM, pH 8.0.
Protein expression and purification. IsdB and IsdBY440A. The gene from S. aureus corresponding to 
IsdB NEAT1 and NEAT2 domains separated by an α–helical linker (UniProt entry Q8NX66, residues 125–485) 
was cloned in the pASK-IBA3plus® vector (IBA Lifesciences) for its expression in E. coli as a fusion protein with 
a C-terminal Strep-tag®II. The protein was purified by affinity chromatography on a StrepTactin® resin (IBA 
Lifesciences). The protein was expressed and purified in high amounts, with a final yield of more than 100 mg/L 
of cell culture. The site-directed mutant Y440A (IsdBY440A) was prepared with standard mutagenesis techniques47 
and purified to homogeneity by the method optimized for the wild type protein.
Hemoglobin and semi-hemoglobins. Human hemoglobin A (Hb) was purified from outdated blood obtained 
from a blood transfusion center. In particular, only hemoglobin from non-smoking donors was purified, as 
described in48. The purified protein in the oxy form was aliquoted, flash-frozen in liquid nitrogen and stored 
at −80 °C until further use. MetHb was obtained by heme oxidation in the presence of potassium ferricyanide. 
Human α and β semihemoglobins (α-semiHb and β-semiHb) were prepared as described in29 by mixing isolated 
α and β chains with apoHb49. Briefly, heme groups were removed by 1:1 liquid-liquid extraction in butanone of 
an aqueous solution of 1 mM Hb, pH 2.5 with 1.0 M HCl. The extraction was repeated three times on the recov-
ered aqueous phase. Before each extraction, the solution was centrifuged to discard the precipitated protein, and 
the pH adjusted to 2.5 with 1.0 M HCl. The final Hb solution was first dialyzed in distilled water to remove the 
excess of butanone dissolved in the aqueous phase, and subsequently in 20 mM potassium phosphate, pH 7.0, and 
100 mM potassium phosphate, 150 mM NaCl, 1 mM EDTA, pH 7.0. ApoHb was finally concentrated to 1.1 mM 
trough diafiltration in an Amicon® stirred cell (Merck) with a 10 kDa cut-off membrane. Holo-α and β chains 
were equilibrated in CO and separately mixed at the final concentration of 312.5 µM with 625 µM apoHb (1:2 
monomer molar ratio) in 5 mL of CO-equilibrated 100 mM potassium phosphate, 150 mM NaCl, 1 mM EDTA, 
pH 7.0. Solutions were incubated statically for about 65 hours at 4 °C, centrifuged for 10 minutes at 10.000 x g at 
4 °C and loaded on a HiLoad 16/600 Superdex 75 prep grade size-exclusion column (GE Healthcare) connected to 
an ÄKTA Prime FPLC system (GE Healthcare), equilibrated with 100 mM potassium phosphate, 150 mM NaCl, 
1 mM EDTA, pH 7.0. The peaks corresponding to the dimeric semiHbs were collected, aliquoted and stored at 
−80 °C until further use.
Spectroscopy and stoichiometry determination. Heme extraction experiments were carried out in the UV-vis 
range using a Cary 4000 spectrophotometer (Varian). Spectra were collected in the 350–700 nm range, while the 
heme-transfer rates were evaluated at 406 nm. The temperature of the cell holder was maintained at 20 °C using 
a circulating water bath, and experimental buffer was composed of 100 mM Tris/HCl, 150 mM NaCl, and 1 mM 
EDTA, pH 8.0. To measure the heme extraction, 1.5 µM hemoglobin (heme concentration) and 7.5 µM IsdB were 
rapidly mixed in a double-chamber cuvette (each chamber has 4.375 mm pathlength). The two chambers are 
separately filled with Hb and IsdB solutions and a spectrum is acquired that is the sum of the two proteins spectra. 
The solutions are then mixed by inverting the cuvette, initiation the reaction. This set-up allows to remove any 
artefact due to sample dilution and protein contribution. The stoichiometric ratio of IsdB:MetHb complex was 
assessed by following the decrease of absorbance at 406 nm in the presence of 5 µM MetHb (heme concentration) 
and increasing concentrations of IsdB wt in the range of 0.3–40 µM. Extinction coefficients used for the determi-
nation of OxyHb and MetHb concentrations are 125,000 cm−1 M−1 at 415 nm and 130,000 cm−1 M−1 at 406 nm, 
respectively, at pH 8.0.
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Surface plasmon resonance. SPR measurements were performed at 25 °C by using a Biacore X100 instru-
ment (GE Healthcare). The StrepMAB-Immo™ (Iba, Goettingen, Germany) was immobilized onto the CM5 sen-
sor chip surface (GE Healthcare) by using the Amine Coupling kit (GE Healthcare) and the HBS-EP + running 
buffer (GE Healthcare), following the procedure reported in refs. 50,51. Briefly, after activation of CM5 sensor 
chip, a solution of StrepMAB-Immo™ (50 μg/mL) in immobilization buffer (10 mM sodium acetate pH 5.0, GE 
Healthcare) was fluxed over the reactive matrix at a flow rate of 10 μL/min for 7 minutes. About 17000 resonance 
units (RU) of StrepMAB-Immo™ were immobilized onto both Flow cell (Fc) 1 and Fc2. The remaining unre-
acted sites were blocked by fluxing 1 M ethanolamine-HCl pH 8.5 (GE Healthcare) for 7 min with a flow rate 
of 10 μL/min over both Fc1 and Fc2. After equilibrating the surface with PBS buffer and 0.005% P20 surfactant 
(GE Healthcare), the ligand, IsdB wt (5 µg/mL), or its mutant IsdBY440A, produced as Strep-Tag fusion proteins, 
was captured onto the Fc2 up to reach a signal of about 1500 RU. SPR measurements were performed by using 
a single-cycle kinetics50,52,53. In particular, five sequential increasing concentrations of Hb (0.01–1 µM) in the 
reaction buffer were fluxed over the sensor chip surface for 160 s with a flow rate of 30 μL/min, followed by a 
160 s dissociation with running buffer and a final dissociation of 400 s with the same buffer, without intermediate 
regeneration. A wizard template was used to automatically perform the analytical cycles and the entire analysis. 
The kinetic parameters were extracted from SPR data through the BiaEvaluation software 2.1 (GE Healthcare), 
using the reference surface Fc1 to correct for systematic noise and instrument drift. Three start up cycles using 
buffer were carried out to equilibrate the surface, followed by a zero concentration cycle of analyte in order to 
have a blank response usable for double reference substraction54. The SPR response as a function of time (called 
sensorgram), was globally fitted by using a 1:1 binding model, a two-state reaction model or a two-state reac-
tion irreversible model. Goodness of the fits was evaluated by χ2 value and residual plots. To extract the kinetic 
parameters of the IsdB:OxyHb interaction, the Langmuir 1:1 binding model, which assumes a simple reversible 
bimolecular reaction between the ligand and the analyte, was applied55,56. The model was modified to take into 
account for the mass transport effect for which the analyte was driven towards the sensor chip surface (Asurface) or 
back again to the bulk solution (Abulk) with the same mass transfer coefficient (kt)57. The analyte, reaching the sen-
sor chip surface, binds to the ligand leading to the formation of the ligand–analyte complex (LA), characterized 
by the association rate constant (kon) and the dissociation rate constant (koff):
+ . . A A L L Abulk
k
k
surface
k
k
t
t
off
on
Accordingly, the variation of Asurface, L and LA concentrations with time can be described by the following set 
of differential equations58.
= − − −
d[A ]
dt
k ([A ] [A ]) (k [L][A ] k [LA])surface t bulk surface on surface off
= − −
d[L]
dt
(k [L][A ] k [LA])on surface off
= −
d[LA]
dt
(k [L][A ] k [LA])on surface off
Data collected with MetHb were analyzed according to a two-state reaction model, modified assuming the 
second step as irreversible (koff2 = 0)
+ ⥫⥬ ⟶ ⃰A L AL AL
K
K K
off1
on1 on2
The sensorgram of the IsdBY440A-MetHb interaction was analyzed by using the two-state reaction model, 
which describes a 1:1 binding of analyte (A), MetHb, to the immobilized ligand (L), IsdBY440A forming the 
AL complex, followed by a conformational change stabilizing the complex (AL*)59. Successively, the complex can 
dissociate through the reverse of the conformational change (two-state reversible):
+ ⥫⥬ ⥫⥬ ⃰A L AL AL
K
K
K
K
off1
on1
off2
on2
Determination of the dissociation constant for the tetramer-dimer equilibrium of hemoglobin. The tetramer-dimer 
dissociation equilibrium of Hb was analyzed through size-exclusion chromatography on a HiLoad 16/600 
Superdex 75 column (GE Healthcare) connected to an ÄKTA Prime FPLC system (GE Healthcare) equilibrated 
with reaction buffer. Hb samples in the oxy and met forms were injected on the column at different concentra-
tions. The dilution factors after elution were calculated according to60.
Molecular modelling. Structure modeling. The following systems were modelled and submitted to 
Molecular Dynamics simulations. The system nomenclature here reported is retained along the manuscript. The 
procedure for preparing the models is reported in Fig. 4.
αβMetHb. Dimeric ferric human aquomethemoglobin (R state; PDB code 3p5q61).
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IsdB:αβMetHb. This model represents the initial complex formed by IsdB and MetHb upon recognition, and 
was built starting from the X-ray structure of IsdB bound to the α chain of dimeric Hb (PDB code 5vmm13). The 
5vmm structure shows a transition state, in which the heme group is displaced towards IsdB and the secondary 
structure of Hb, in particular at the helix F level, is severely altered by the presence of the hemophore. Thus, the 
original Hb dimer was replaced by the 3p5q structure, not altered by the hemophore presence. Residues at the 
IsdB:αHb chain interface were properly modelled to avoid clashes.
IsdB:βαMetHb. Following the same protocol, the hemophore structure was retained from the 5vmm X-ray 
structure, while the Hb replaced with the 3p5q structure. β and α chains were inverted to simulate IsdB bound to 
the β chain of dimeric MetHb.
holoIsdB:apo-αβMetHb. This model should represent the final step of the IsdB: αβMetHb interaction, upon 
the heme transfer and before the complex detachment. Here, the heme is located in the NEAT2 domain of a holo 
IsdB, while the MetHb α chain is in the apo form. In the IsdB:αβMetHb complex the IsdB NEAT2 domain was 
replaced with the X-ray structure of a heme-bound NEAT2 (PDB code 3rtl22). The heme was removed by the 
MetHb α chain and the residues at the IsdB:Hb interface were properly modelled to avoid clashes.
IsdB:αβOxyHb. Again, the 5vmm complex was used as a template. The dimeric Hb was replaced by the dimeric 
oxygenated form of ferrous human Hb (PDB code 2dn162). The complex interface was properly modelled.
IsdBY440A:αβMetHb. Starting from 5vmm X-ray structure, the same protocol reported for IsdB:αβMetHb was 
followed, adding a mutation of residue Tyr440 → Ala in IsdB.
System set-up. Ionizable residues were assigned standard protonation states at physiological pH. All histidines 
were kept in the default tautomeric (Nε-H) state, with the exception of the proximal and distal histidine63. In 
MetHb, the proximal and distal histidine residues coordinating the hemic iron were both Nδ-H protomers, while 
in the oxygenated hemoglobin the proximal and distal histidines were simulated as Nδ-H and Nε-H protomers, 
respectively. The parameters for the water- or oxygen-coordinating heme groups were calculated and tested in 
previous works64,65. Before the MD production, each complex was embedded in a cubic box and solvated in TIP3P 
water molecules, with addition of Na+ and Cl− as counterions for neutralizing the total charge. The LINCS algo-
rithm was employed to fix bond length between hydrogens and heavy atoms at the equilibrium distance. Periodic 
boundary conditions (PBC) were set, long range electrostatic effects were adjusted with the Particle-Mesh Ewald 
(PME) method, a cut-off value of 11 Å was fixed for both electrostatic and van der Waals interactions. The box was 
built using the BiKi software suite (http://www.bikitech.com/)66,67.
MD simulations. The complexes underwent 1·106 energy minimization cycles using the steepest descend-
ant algorithm, then a slow equilibration (four steps in isothermal-isochoric (NVT) and two steps in the 
isothermal-isobaric canonical (NPT) ensembles, respectively) was performed for heating the system from 0 to 
300 K, with a temperature ramp of 50 K every 1 ns. The Newton’s equation was integrated every 2 fs, collecting 
frames every 10 ps, rescaling velocities with the Berendsen thermostat to control the temperature and coupling 
the system in NPT to a Parrinello-Rahman barostat. Lastly, a short equilibration of 2 ns in the NPT ensemble 
at 300 K was carried out before the 1 μs-long simulation in NVT ensemble. A total amount of about 6 μs was 
simulated.
Essential Dynamics. Essential motions in the near-constraints subspace were sampled by means of Essential 
Dynamics (ED) - or Principal Component Analysis (PCA) - to highlight the modes that contribute mostly to 
the overall dynamicity of the complex. After a least square fit to remove roto-translations, the covariance matrix 
of atomic displacement was calculated and then diagonalized, the eigenvectors were sorted by their eigenvalues. 
Among the resulting ranked top 10 eigenvectors, the first and the second describe the largest structural variance 
of the system and were thus taken into account for reducing complex motions to the essential subspace. In most 
cases their behavior is quite similar and the first, explaining the highest variance percentage, was chosen for the 
following PCA analysis. For each simulation, extreme conformations of the trajectory were collected and pro-
jected along the first eigenvector. The ED of IsdB and Hb were carried out separately in all the systems, to investi-
gate how IsdB affects the motion and, thus, the function of Hb, and vice versa (Figs. 7 and S5).
The cosine content (ci) of the first eigenvector was extracted from the covariance matrix to analyze the protein 
behavior along the first principal component, which explains the highest percentage contribution to the overall 
variance. The cosine content (ci) is a value ranging between 0 (no cosine) and 1 (perfect cosine), where a ci value 
close to 1 describes a motion resembling random diffusion close to an equilibrium conformation, while a ci close 
to 0 indicates a mode likely linked to a structural transition. It is generally considered that ci is higher than 0.5 
when the structure oscillates around an equilibrium state, while ci < 0.5 indicates a non-harmonic movement 
usually related to a structural transition having a biological meaning68.
All MD simulations and analyses were carried out with GROMACS software 4.5.1 version69. Plots were gener-
ated with MatLab software (MathWorks, Inc.)70. Pictures were prepared using PyMOL v1.7.6.4.
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